Preferential Production of Interleukin-1 Beta over Interleukin-1 Receptor Antagonist Contributes to Proliferation and Suppression of Apoptosis in Leukemic Cells

Overview

Journal Jpn J Cancer Res

Specialty Oncology

Date 1995 Feb 1

PMID 7730146

Citations 3

Authors

Y Furukawa

J Kikuchi

Y Terui

S Kitagawa

M Ohta

Y Miura

M Saito

Affiliations

Soon will be listed here.

Abstract

Normal human monocytes were isolated in a nascent state by centrifugal elutriation and used for the study of interleukin-1 (IL-1) and interleukin-1 receptor antagonist (IL-1ra) expression. Neither IL-1 beta nor IL-1ra mRNA was present in monocytes just after the isolation, but they were induced simultaneously in response to various stimulants. In contrast, only IL-1 beta mRNA was expressed in monocytic leukemia cell line JOSK-1, while little or no IL-1ra mRNA was detected even after stimulation. Dominant expression of IL-1 beta over IL-1ra was also observed in fresh leukemia cells including monocytic leukemias, i.e., IL-1 beta mRNA was constitutively expressed in 26 out of 36 cases (72.2%), whereas IL-1ra mRNA was present only in 8 cases (22.2%). The signal intensity of IL-1 beta mRNA was stronger than that of IL-1ra even in IL-1ra-positive cases. Apoptotic cell death of monocytes was significantly inhibited by IL-1 beta, and it was enhanced by IL-1ra. In fresh leukemia cells, 3H-thymidine uptake was generally higher in IL-1-producing cases than in IL-1ra-producing cases, and was increased by the addition of IL-1 beta in all cases tested. Cell proliferation was inhibited by either IL-1ra or anti-IL-1 beta antibody in IL-1-producing cases, while it was enhanced by anti-IL-1ra antibody in IL-1ra-producing cases. These results suggest that the balance between IL-1 and IL-1ra is necessary for homeostasis of the mononuclear phagocytosis system. The imbalance between these two counter-acting cytokines might contribute to the altered growth and accumulation of leukemic cells.

Citing Articles

Analysis of the expression and potential molecular mechanism of interleukin-1 receptor antagonist (IL1RN) in papillary thyroid cancer via bioinformatics methods.

Xie Z, Li X, He Y, Wu S, Wang S, Sun J BMC Cancer. 2020; 20(1):1143.

PMID: 33238942 PMC: 7687764. DOI: 10.1186/s12885-020-07620-8.

IL-1ra and IL-1 production in human oral mucosal epithelial cells in culture: differential modulation by TGF-beta1 and IL-4.

Perrier S, Kherratia B, Deschaumes C, Ughetto S, Kemeny J, Baudet-Pommel M Clin Exp Immunol. 2002; 127(1):53-9.

PMID: 11882032 PMC: 1906287. DOI: 10.1046/j.1365-2249.2002.01685.x.

Overexpression of IL-1ra gene up-regulates interleukin-1beta converting enzyme (ICE) gene expression: possible mechanism underlying IL-1beta-resistance of cancer cells.

Sumitomo M, Tachibana M, Murai M, Hayakawa M, Nakamura H, Takayanagi A Br J Cancer. 1999; 81(2):277-86.

PMID: 10496353 PMC: 2362876. DOI: 10.1038/sj.bjc.6690688.

References

Nakamura M, Kanakura Y, Furukawa Y, Ernst T, Griffin J . Demonstration of interleukin-1 beta transcripts in acute myeloblastic leukemic cells by in situ hybridization. Leukemia. 1990; 4(7):466-70. View

Estrov Z, Kurzrock R, Wetzler M, Kantarjian H, Blake M, Harris D . Suppression of chronic myelogenous leukemia colony growth by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors: a novel application for inhibitors of IL-1 activity. Blood. 1991; 78(6):1476-84. View

CARTER D, Deibel Jr M, Dunn C, Tomich C, Laborde A, Slightom J . Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature. 1990; 344(6267):633-8. DOI: 10.1038/344633a0. View

Yuo A, Kitagawa S, Motoyoshi K, Azuma E, Saito M, Takaku F . Rapid priming of human monocytes by human hematopoietic growth factors: granulocyte-macrophage colony-stimulating factor (CSF), macrophage-CSF, and interleukin-3 selectively enhance superoxide release triggered by receptor-mediated agonists. Blood. 1992; 79(6):1553-7. View

Hannum C, Wilcox C, Arend W, Joslin F, Dripps D, Heimdal P . Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature. 1990; 343(6256):336-40. DOI: 10.1038/343336a0. View

Granowitz E, Santos A, Poutsiaka D, Cannon J, Wilmore D, Wolff S . Production of interleukin-1-receptor antagonist during experimental endotoxaemia. Lancet. 1991; 338(8780):1423-4. DOI: 10.1016/0140-6736(91)92725-h. View

Janson R, Hance K, Arend W . Production of IL-1 receptor antagonist by human in vitro-derived macrophages. Effects of lipopolysaccharide and granulocyte-macrophage colony-stimulating factor. J Immunol. 1991; 147(12):4218-23. View

Arend W, Dayer J . Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum. 1990; 33(3):305-15. DOI: 10.1002/art.1780330302. View

Lang R, Metcalf D, Cuthbertson R, Lyons I, Stanley E, Kelso A . Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage. Cell. 1987; 51(4):675-86. DOI: 10.1016/0092-8674(87)90136-x. View

10.

Smith Jr M, Eidlen D, Brewer M, Eisenberg S, Arend W, Gutierrez-Hartmann A . Human IL-1 receptor antagonist promoter. Cell type-specific activity and identification of regulatory regions. J Immunol. 1992; 149(6):2000-7. View

11.

Granowitz E, Porat R, Mier J, Orencole S, Callahan M, Cannon J . Hematologic and immunomodulatory effects of an interleukin-1 receptor antagonist coinfusion during low-dose endotoxemia in healthy humans. Blood. 1993; 82(10):2985-90. View

12.

Furukawa Y, Uenoyama S, Ohta M, Tsunoda A, Griffin J, Saito M . Transforming growth factor-beta inhibits phosphorylation of the retinoblastoma susceptibility gene product in human monocytic leukemia cell line JOSK-I. J Biol Chem. 1992; 267(24):17121-7. View

13.

Cannistra S, Griffin J . Regulation of the production and function of granulocytes and monocytes. Semin Hematol. 1988; 25(3):173-88. View

14.

Nathan C . Secretory products of macrophages. J Clin Invest. 1987; 79(2):319-26. PMC: 424063. DOI: 10.1172/JCI112815. View

15.

Arend W, Joslin F, Thompson R, Hannum C . An IL-1 inhibitor from human monocytes. Production and characterization of biologic properties. J Immunol. 1989; 143(6):1851-8. View

16.

Furukawa Y, Ohta M, Miura Y, Saito M . Interleukin 1 production by monocytic leukemia cells and its possible role in coagulation abnormalities. Leuk Res. 1991; 15(12):1133-7. DOI: 10.1016/0145-2126(91)90181-r. View

17.

Schiro R, Longoni D, Rossi V, Maglia O, Doni A, Arsura M . Suppression of juvenile chronic myelogenous leukemia colony growth by interleukin-1 receptor antagonist. Blood. 1994; 83(2):460-5. View

18.

Ohta M, Furukawa Y, Ide C, Akiyama N, UTAKOJI T, Miura Y . Establishment and characterization of four human monocytoid leukemia cell lines (JOSK-I, -S, -M and -K) with capabilities of monocyte-macrophage lineage differentiation and constitutive production of interleukin 1. Cancer Res. 1986; 46(6):3067-74. View

19.

Williams G, Smith C, Spooncer E, Dexter T, Taylor D . Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature. 1990; 343(6253):76-9. DOI: 10.1038/343076a0. View

20.

Arend W, Smith Jr M, Janson R, Joslin F . IL-1 receptor antagonist and IL-1 beta production in human monocytes are regulated differently. J Immunol. 1991; 147(5):1530-6. View